Asahi Glass which has a CMO subsidiary in Japan focused on Schizosaccharomyces pombe as a cell factory has acquired German Biomeva in Heidelberg, a CMO specialist for pharmaceutical products whose main hosts are E. coli and yeast. Fermentation capacities are in the 10L, 100L and 1000L scale at biosafety level (BSL) 1. Some production is also possible at BSL2.
Asahi Glass news release, Sept. 8, 2016
Asahi Glass acquires German Biomeva, more contract manufacturing in Europe